Ignite Creation Date:
2024-05-06 @ 10:03 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03144856
Status:
UNKNOWN
Last Update Posted:
2017-05-09
First Post:
2017-05-05
Brief Title:
Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
Sponsor:
Organization:
Sun Yat-sen University